Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
Objective. Demonstrate the efficiency of therapy for antiphospholipid syndrome (APS) in pregnant women using plasmapheresis and intravenous immunoglobulins. Materials and methods. 92 women with diagnosed APS and 47 women without APS with physiological pregnancy were examined. Patients were divided...
Main Authors: | Ekaterina Sergeevna Orlova, Sergey Vladimirovich Chepanov, Marina Sabirovna Zainulina, Sergey Alexeevich Selkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2019-08-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2893 |
Similar Items
-
USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01) -
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01) -
Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome
by: Yoko Maesawa, et al.
Published: (2018-04-01) -
Use of plasmapheresis in treatment of patients with unfavorable anamnestic pregnancy outcomes coupled to antiphospholipid antibodies
by: D. R. Eremeeva, et al.
Published: (2021-03-01) -
Obstetric antiphospholipid syndrome: An approach from glycans of the immunoglobulin G
by: Angela Maria Alvarez, et al.
Published: (2021-01-01)